Gambia vs Panama: HIV/AIDS deaths averted by antiretroviral therapy
Gambia
883.72 deaths
in 2024
Panama
934.45 deaths
in 2024
Gambia rank
77th
Panama rank
76th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Gambia
- Panama
How they compare
Panama currently reports 934.45 deaths against 883.72 deaths in Gambia, a difference of 50.73 deaths.
That makes Panama's figure about 1.1 times Gambia's.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Panama ahead.
Gambia ranks 77th and Panama ranks 76th of 157 countries.
Across the 4 decades both report, Gambia averaged higher in 1 and Panama in 3.
Head to head by decade
| Decade | Gambia | Panama | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 8.02 deaths | 8.02 deaths | Panama |
| 2000s | 59.36 deaths | 346.22 deaths | 286.86 deaths | Panama |
| 2010s | 595.79 deaths | 668.17 deaths | 72.38 deaths | Panama |
| 2020s | 789.23 deaths | 769.48 deaths | 19.75 deaths | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Gambia or Panama?
- Panama, at 934.45 deaths against 883.72 deaths in Gambia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Gambia and Panama?
- 50.73 deaths, with Panama ahead.
- How many years of comparable data are there for Gambia and Panama?
- 35 years are reported by both, from 1990 to 2024.
- How do Gambia and Panama rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Gambia ranks 77th and Panama ranks 76th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.